Bifidobacterium pseudocatenulatum CECT7765 promotes a TLR2-dependent anti-inflammatory response in intestinal lymphocytes from mice with cirrhosis

European Journal of Nutrition

Volumn 55, Issue 1, 2016, Pages 197-206

  Moratalla, Alba ^a,b   Gómez Hurtado, Isabel ^a   Moya Pérez, Ángela ^c   Zapater, Pedro ^a,b   Peiró, Gloria ^b   González Navajas, José M ^a,b   Gómez Del Pulgar, Eva Maria ^c   Such, José ^a,d   Sanz, Yolanda ^c   Francés, Rubén ^a,b,d  

^a INSTITUTO DE SALUD CARLOS III   (Spain)

^b HOSPITAL GENERAL UNIVERSITARIO DE ALICANTE   (Spain)

^c INSTITUTO DE AGROQUÍMICA Y TECNOLOGÍA DE ALIMENTOS CSIC   (Spain)

^d MIGUEL HERNÁNDEZ UNIVERSITY   (Spain)

Author keywords

B. pseudocatenulatum CECT7765; Cirrhosis; Endotoxin; Inflammation; Intestinal lymphocytes; Toll like receptor 2

Indexed keywords

BACTERIAL ANTIGEN; CARBON TETRACHLORIDE; CHEMOKINE RECEPTOR CCR6; CHEMOKINE RECEPTOR CCR9; CHEMOKINE RECEPTOR CXCR3; CHEMOKINE RECEPTOR CXCR6; CYTOKINE; INTERLEUKIN 10 RECEPTOR; NATURAL PRODUCT; PLACEBO; TOLL LIKE RECEPTOR 2; TUMOR NECROSIS FACTOR ALPHA; CC CHEMOKINE RECEPTOR 9; CCR6 PROTEIN, MOUSE; CHEMOKINE RECEPTOR CCR; CHEMOKINE RECEPTOR CXCR; CXCR3 PROTEIN, MOUSE; CXCR6 PROTEIN, MOUSE; IL10 PROTEIN, MOUSE; INTERLEUKIN 10; PROBIOTIC AGENT; TLR2 PROTEIN, MOUSE; TUMOR NECROSIS FACTOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIINFLAMMATORY ACTIVITY; ARTICLE; BACTERIAL STRAIN; BIFIDOBACTERIUM; BIFIDOBACTERIUM PSEUDOCATENULATUM; CELL ISOLATION; CONTROLLED STUDY; CYTOKINE RESPONSE; FEMALE; IN VIVO STUDY; INFLAMMATION; INTESTINE CELL; INTESTINE MUCOSA PERMEABILITY; LAPAROTOMY; LIVER CIRRHOSIS; LIVER FUNCTION; LYMPHOCYTE; MOUSE; NONHUMAN; PROTEIN EXPRESSION; REGULATORY MECHANISM; T LYMPHOCYTE SUBPOPULATION; ANIMAL; ANTAGONISTS AND INHIBITORS; BAGG ALBINO MOUSE; CHEMICALLY INDUCED; CYTOLOGY; DISEASE MODEL; GENETICS; HOMEOSTASIS; INTESTINE; INTESTINE FLORA; LIVER; METABOLISM; MICROBIOLOGY; PERMEABILITY;

ANIMALS; BIFIDOBACTERIUM; CARBON TETRACHLORIDE; DISEASE MODELS, ANIMAL; FEMALE; GASTROINTESTINAL MICROBIOME; HOMEOSTASIS; INTERLEUKIN-10; INTESTINES; LIVER; LIVER CIRRHOSIS; LYMPHOCYTES; MICE; MICE, INBRED BALB C; PERMEABILITY; PROBIOTICS; RECEPTORS, CCR; RECEPTORS, CCR6; RECEPTORS, CXCR; RECEPTORS, CXCR3; TOLL-LIKE RECEPTOR 2; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84957440065     PISSN: 14366207     EISSN: 14366215     Source Type: Journal    
DOI: 10.1007/s00394-015-0837-x     Document Type: Article

References (39)

1. Berg RD (1992) Bacterial translocation from the gastrointestinal tract. J Med 23:217–244
2. Wiest R, Garcia-Tsao G (2005) Bacterial translocation (BT) in cirrhosis. Hepatology 41:422–433
3. Yan AW, Fouts DE, Brandl J, Starkel P, Torralba M, Schott E et al (2011) Enteric dysbiosis associated with a mouse model of alcoholic liver disease. Hepatology 53:96–105
4. Gomez-Hurtado I, Santacruz A, Peiro G, Zapater P, Gutierrez A, Perez-Mateo M et al (2011) Gut microbiota dysbiosis is associated with inflammation and bacterial translocation in mice with CCl4-induced fibrosis. PLoSOne 6:e23037
5. Kirpich IA, McClain CJ (2012) Probiotics in the treatment of the liver diseases. J Am Coll Nutr 31:14–23
6. Stadlbauer V, Mookerjee RP, Hodges S, Wright GA, Davies NA, Jalan R (2008) Effect of probiotic treatment on deranged neutrophil function and cytokine responses in patients with compensated alcoholic cirrhosis. J Hepatol 48:945–951
7. Pereg D, Kotliroff A, Gadoth N, Hadary R, Lishner M, Kitay-Cohen Y (2011) Probiotics for patients with compensated liver cirrhosis: a double-blind placebo-controlled study. Nutrition 27:177–181
8. Moratalla A, Gomez-Hurtado I, Santacruz A, Moya A, Peiro G, Zapater P, et al. (2014) Protective effect of Bifidobacterium pseudocatenulatum CECT7765 against induced bacterial antigen translocation in experimental cirrhosis. Liver Int 34:850–858
9. Agace WW (2006) Tissue-tropic effector T cells: generation and targeting opportunities. Nat Rev Immunol 6:682–692
10. de Kivit S, Tobin MC, Forsyth CB, Keshavarzian A, Landay AL (2014) Regulation of intestinal immune responses through TLR activation: implications for pro- and prebiotics. Front Immunol 5:60
11. Jeon SG, Kayama H, Ueda Y, Takahashi T, Asahara T, Tsuji H et al (2012) Probiotic Bifidobacterium breve induces IL-10-producing Tr1 cells in the colon. PLoS Pathog 8:e1002714
12. Isono A, Katsuno T, Sato T, Nakagawa T, Kato Y, Sato N et al (2007) Clostridium butyricum TO-A culture supernatant downregulates TLR4 in human colonic epithelial cells. Dig Dis Sci 52:2963–2971
13. Hayashi A, Sato T, Kamada N, Mikami Y, Matsuoka K, Hisamatsu T et al (2013) A single strain of Clostridium butyricum induces intestinal IL-10-producing macrophages to suppress acute experimental colitis in mice. Cell Host Microbe 13:711–722
14. Mazmanian SK, Round JL, Kasper DL (2008) A microbial symbiosis factor prevents intestinal inflammatory disease. Nature 453:620–625
15. Vizoso Pinto MG, Rodriguez Gomez M, Seifert S, Watzl B, Holzapfel WH, Franz CM (2009) Lactobacilli stimulate the innate immune response and modulate the TLR expression of HT29 intestinal epithelial cells in vitro. Int J Food Microbiol 133:86–93
16. Furrie E, Macfarlane S, Thomson G, Macfarlane GT, Microbiology and Gut Biology Group et al (2005) Toll-like receptors-2, -3 and -4 expression patterns on human colon and their regulation by mucosal-associated bacteria. Immunology 115:565–574
17. Kingma SD, Li N, Sun F, Valladares RB, Neu J, Lorca GL (2011) Lactobacillus johnsonii N6.2 stimulates the innate immune response through Toll-like receptor 9 in Caco-2 cells and increases intestinal crypt Paneth cell number in biobreeding diabetes-prone rats. J Nutr 141:1023–1028
18. Such J, Frances R, Munoz C, Zapater P, Casellas JA, Cifuentes A et al (2002) Detection and identification of bacterial DNA in patients with cirrhosis and culture-negative, nonneutrocytic ascites. Hepatology 36:135–141
19. Guarner C, Gonzalez-Navajas JM, Sanchez E, Soriano G, Frances R, Chiva M et al (2006) The detection of bacterial DNA in blood of rats with CCl(4)-induced cirrhosis with ascites represents episodes of bacterial translocation. Hepatology 44:633–639
20. Gautreaux MD, Gelder FB, Deitch EA, Berg RD (1995) Adoptive transfer of T lymphocytes to T-cell-depleted mice inhibits Escherichia coli translocation from the gastrointestinal tract. Infect Immun 63:3827–3834
21. Choudhry MA, Fazal N, Goto M, Gamelli RL, Sayeed MM (2002) Gut-associated lymphoid T cell suppression enhances bacterial translocation in alcohol and burn injury. Am J Physiol Gastrointest Liver Physiol 282:G937–G947
22. Stenstad H, Ericsson A, Johansson-Lindbom B, Svensson M, Marsal J, Mack M et al (2006) Gut-associated lymphoid tissue-primed CD4 + T cells display CCR9-dependent and -independent homing to the small intestine. Blood 107:3447–3454
23. Chu PS, Nakamoto N, Ebinuma H, Usui S, Saeki K, Matsumoto A et al (2013) C-C motif chemokine receptor 9 positive macrophages activate hepatic stellate cells and promote liver fibrosis in mice. Hepatology 58:337–350
24. Hammerich L, Bangen JM, Govaere O, Zimmermann HW, Gassler N, Huss S et al (2014) Chemokine receptor CCR6-dependent accumulation of gammadelta T cells in injured liver restricts hepatic inflammation and fibrosis. Hepatology 59:630–642
25. Helwig U, Lammers KM, Rizzello F, Brigidi P, Rohleder V, Caramelli E et al (2006) Lactobacilli, Bifidobacteria and E. coli nissle induce pro- and anti-inflammatory cytokines in peripheral blood mononuclear cells. World J Gastroenterol 12:5978–5986
26. Medina M, Izquierdo E, Ennahar S, Sanz Y (2007) Differential immunomodulatory properties of Bifidobacterium logum strains: relevance to probiotic selection and clinical applications. Clin Exp Immunol 150:531–538
27. Agrawal S, Agrawal A, Doughty B, Gerwitz A, Blenis J, Van Dyke T et al (2003) Cutting edge: different Toll-like receptor agonists instruct dendritic cells to induce distinct Th responses via differential modulation of extracellular signal-regulated kinase-mitogen-activated protein kinase and c-Fos. J Immunol 171:4984–4989
28. Dillon S, Agrawal A, Van Dyke T, Landreth G, McCauley L, Koh A et al (2004) A Toll-like receptor 2 ligand stimulates Th2 responses in vivo, via induction of extracellular signal-regulated kinase mitogen-activated protein kinase and c-Fos in dendritic cells. J Immunol 172:4733–4743
29. Redecke V, Hacker H, Datta SK, Fermin A, Pitha PM, Broide DH et al (2004) Cutting edge: activation of Toll-like receptor 2 induces a Th2 immune response and promotes experimental asthma. J Immunol 172:2739–2743
30. Plantinga TS, van Maren WW, van Bergenhenegouwen J, Hameetman M, Nierkens S, Jacobs C et al (2011) Differential Toll-like receptor recognition and induction of cytokine profile by Bifidobacterium breve and Lactobacillus strains of probiotics. Clin Vaccine Immunol 18:621–628
31. Hartmann P, Haimerl M, Mazagova M, Brenner DA, Schnabl B (2012) Toll-like receptor 2-mediated intestinal injury and enteric tumor necrosis factor receptor I contribute to liver fibrosis in mice. Gastroenterology 143(1330–1340):e1331
32. Frances R, Zapater P, Gonzalez-Navajas JM, Munoz C, Cano R, Moreu R et al (2008) Bacterial DNA in patients with cirrhosis and noninfected ascites mimics the soluble immune response established in patients with spontaneous bacterial peritonitis. Hepatology 47:978–985
33. Moorthy G, Murali MR, Devaraj SN (2009) Lactobacilli facilitate maintenance of intestinal membrane integrity during Shigella dysenteriae 1 infection in rats. Nutrition 25:350–358
34. Khailova L, Dvorak K, Arganbright KM, Halpern MD, Kinouchi T, Yajima M et al (2009) Bifidobacterium bifidum improves intestinal integrity in a rat model of necrotizing enterocolitis. Am J Physiol Gastrointest Liver Physiol 297:G940–G949
35. Mennigen R, Nolte K, Rijcken E, Utech M, Loeffler B, Senninger N et al (2009) Probiotic mixture VSL#3 protects the epithelial barrier by maintaining tight junction protein expression and preventing apoptosis in a murine model of colitis. Am J Physiol Gastrointest Liver Physiol 296:G1140–G1149
36. Zhou YK, Qin HL, Zhang M, Shen TY, Chen HQ, Ma YL et al (2012) Effects of Lactobacillus plantarum on gut barrier function in experimental obstructive jaundice. World J Gastroenterol 18:3977–3991
37. Sanchez E, Nieto JC, Boullosa A, Vidal S, Sancho FJ, Rossi G, et al. (2014) VSL#3 probiotic treatment decreases bacterial translocation in rats with carbon tetrachloride-induced cirrhosis. Liver Int 34:1504–1512
38. Velayudham A, Dolganiuc A, Ellis M, Petrasek J, Kodys K, Mandrekar P et al (2009) VSL#3 probiotic treatment attenuates fibrosis without changes in steatohepatitis in a diet-induced nonalcoholic steatohepatitis model in mice. Hepatology 49:989–997
39. Li Z, Yang S, Lin H, Huang J, Watkins PA, Moser AB et al (2003) Probiotics and antibodies to TNF inhibit inflammatory activity and improve nonalcoholic fatty liver disease. Hepatology 37:343–350